Matheus Nathanael
1506739085
KD - 15
Patogenesis & Patofisiologi HSV 1
Analgesia
Acetaminophen, codeine
Anestetik topical provide relief
Lidocaine
Meskipun dapat percepat penyembuhan dan
mengurangi gejala tidak bisa eradikasi virus
laten/tidak mengurangi kemungkinan infeksi
rekuren
Symptom minimal terapi tidak harus
Episodic therapy for recurrent disease inisiasi
terapi saat prodrom (bila ada) dan 1 hari setelah
lesi muncul
Suppressive therapy kurangi lesi rekuren 70%-
80%, kurangi transmisi melalui seks sekitar 50%
(Corey, 2004)
Patogenesis & Patofisiologi HPV 1,2,3
Manifestasi
Klinis
Onkogenitas Vaksinasi
Bivalent HPV (HPV2) vaccine
(Cervarix, GlaxoSmithKline)
Each 0.5-mL dose contains
20 micrograms of HPV type
16 L1 protein and
20 micrograms of HPV type
18 L1 protein
Quadrivalent HPV (HPV4)
vaccine (Gardasil, Merck)
Each 0.5-mL dose of HPV4
contains
20 micrograms HPV 6 L1
protein,
40 micrograms HPV 11 L1
protein,
40 micrograms HPV 16 L1
protein, and
20 micrograms HPV 18 L1
protein
Referensi
1.Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JL, et all. Williams
gynecology. 3rd ed. . New York: McGraw-Hill Education; 2016. p.55,627-9
2.Lentz GM, Lobo RA, Gershenson DM, Katz KL. Comprehensive gynecology. 6th ed.
Philadelphia: Elsevier; 2012. p.523-5, 653
3.Impey L, Child T. Obstetrics & Gynaecology. 4th ed. West Sussex: John Wiley&Sons.
2012. p.33-8,74-5
4.Symonds I, Arulkumaran SS, Symonds EM. Essential Obstetrics and Gynaecology.
5th ed. Philadelphia: Elsevier; 2013. p.307-8
5.CDC. Human papillomavirus vaccination. Recommendations
of the Advisory Committee on Immunization Practices
(ACIP). MMWR 2014;63(No. 5):1-30.